These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


573 related items for PubMed ID: 25455853

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
    Ververs TF, van Dijk A, Vinks SA, Blankestijn PJ, Savelkoul JF, Meulenbelt J, Boereboom FT.
    Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot study.
    Langan KM, Jacob J, Li J, Nation RL, Bellomo R, Howden B, Johnson PD.
    Crit Care Resusc; 2014 Sep; 16(3):190-6. PubMed ID: 25161021
    [Abstract] [Full Text] [Related]

  • 10. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R, RENAL Replacement Therapy Study Investigators.
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W, Jitsurong A, Wiwattanawongsa K, Wanakamanee U, Dandecha P.
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
    Gao C, Tong J, Yu K, Sun Z, An R, Du Z.
    Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
    [Abstract] [Full Text] [Related]

  • 14. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J.
    Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.
    Adnan S, Li JX, Wallis SC, Rudd M, Jarrett P, Paterson DL, Lipman J, Udy AA, Roberts JA.
    Int J Antimicrob Agents; 2013 Jul; 42(1):90-3. PubMed ID: 23590897
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ, Jennings AC, Thomson AH, Creed G, Beale RJ, McLuckie A.
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [Abstract] [Full Text] [Related]

  • 17. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.
    Thalhammer F, Schenk P, Burgmann H, El Menyawi I, Hollenstein UM, Rosenkranz AR, Sunder-Plassmann G, Breyer S, Ratheiser K.
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2417-20. PubMed ID: 9736573
    [Abstract] [Full Text] [Related]

  • 18. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA, Udy AA, Lipman J, Roberts JA.
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW.
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.